Prostate Cancer and Prostatic Diseases - Table of Contents alert Volume 19 Issue 1

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 19, Issue 1 (March 2016) In this issue Reviews Original Articles Also new AOP Sign up for e-alerts Twitter Recommend to your library Web feed Subscribe Reviews Top Which, when and why? Rational use of tissue-based molecular testing in localized prostate cancer A E Ross, A V D'Amico and S J Freedland Prostate Cancer Prostatic Dis 2016 19: 1-6; advance online publication, June 30, 2015; 10.1038/pcan.2015.31 Abstract | Full Text Metabolic syndrome, inflammation and lower urinary tract symptoms: possible translational links Q He, Z Wang, G Liu, F Daneshgari, G T MacLennan and S Gupta Prostate Cancer Prostatic Dis 2016 19: 7-13; advance online publication, September 22, 2015; 10.1038/pcan.2015.43 Abstract | Full Text Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer V Mouraviev, B Lee, V Patel, D Albala, T E B Johansen, A Partin, A Ross and R J Perera Prostate Cancer Prostatic Dis 2016 19: 14-20; advance online publication, October 27, 2015; 10.1038/pcan.2015.48 Abstract | Full Text Original Articles Top Oral simvastatin administration delays castration-resistant progression and reduces intratumoral steroidogenesis of LNCaP prostate cancer xenografts J A Gordon, A Midha, A Szeitz, M Ghaffari, H H Adomat, Y Guo, T L Klassen, E S Guns, K M Wasan and M E Cox Prostate Cancer Prostatic Dis 2016 19: 21-27; advance online publication, August 4, 2015; 10.1038/pcan.2015.37 Abstract | Full Text Association between single-nucleotide polymorphisms in DNA double-strand break repair genes and prostate cancer aggressiveness in the Spanish population L A Henríquez-Hernández, A Valenciano, P Foro-Arnalot, M J Álvarez-Cubero, J M Cozar, J F Suárez-Novo, M Castells-Esteve, P Fernández-Gonzalo, B De-Paula-Carranza, M Ferrer, F Guedea, G Sancho-Pardo, J Craven-Bartle, M J Ortiz-Gordillo, P Cabrera-Roldán, J I Rodríguez-Melcón, E Herrera-Ramos, C Rodríguez-Gallego and P C Lara Prostate Cancer Prostatic Dis 2016 19: 28-34; advance online publication, January 12, 2016; 10.1038/pcan.2015.63 Abstract | Full Text Metabolic abnormalities linked to an increased cardiovascular risk are associated with high-grade prostate cancer: a single biopsy cohort analysis C De Nunzio, G Truscelli, A Trucchi, S Petta, M Tubaro, M Gacci, C Gaudio, F Presicce and A Tubaro Prostate Cancer Prostatic Dis 2016 19: 35-39; advance online publication, October 6, 2015; 10.1038/pcan.2015.45 Abstract | Full Text Evaluation of an epithelial plasticity biomarker panel in men with localized prostate cancer A J Armstrong, P Healy, S Halabi, R Vollmer, A Lark, G Kemeny, K Ware and S J Freedland Prostate Cancer Prostatic Dis 2016 19: 40-45; advance online publication, October 13, 2015; 10.1038/pcan.2015.46 Abstract | Full Text Focal irreversible electroporation for prostate cancer: functional outcomes and short-term oncological control F Ting, M Tran, M Böhm, A Siriwardana, P J Van Leeuwen, A-M Haynes, W Delprado, R Shnier and P D Stricker Prostate Cancer Prostatic Dis 2016 19: 46-52; advance online publication, October 13, 2015; 10.1038/pcan.2015.47 Abstract | Full Text Aspirin and NSAID use in association with molecular subtypes of prostate cancer defined by TMPRSS2:ERG fusion status J L Wright, L Chéry, S Holt, D W Lin, M Luedeke, A E Rinckleb, C Maier and J L Stanford Prostate Cancer Prostatic Dis 2016 19: 53-56; advance online publication, October 27, 2015; 10.1038/pcan.2015.49 Abstract | Full Text Influence of 1 year of androgen deprivation therapy on lipid and glucose metabolism and fat accumulation in Japanese patients with prostate cancer K Mitsuzuka, A Kyan, T Sato, K Orikasa, M Miyazato, H Aoki, N Kakoi, S Narita, T Koie, T Namima, S Toyoda, Y Fukushi, T Habuchi, C Ohyama, Y Arai, The Tohoku Evidence-Based Medicine Study Group and The Michinoku Urological Cancer Study Group Prostate Cancer Prostatic Dis 2016 19: 57-62; advance online publication, October 27, 2015; 10.1038/pcan.2015.50 Abstract | Full Text Determinants of long-term survival of patients with locally advanced prostate cancer: the role of extensive pelvic lymph node dissection M Moschini, N Fossati, F Abdollah, G Gandaglia, V Cucchiara, P Dell'Oglio, S Luzzago, S F Shariat, F Dehò, A Salonia, F Montorsi and A Briganti Prostate Cancer Prostatic Dis 2016 19: 63-67; advance online publication, November 10, 2015; 10.1038/pcan.2015.51 Abstract | Full Text Atypical small acinar proliferation (ASAP): Is a repeat biopsy necessary ASAP? A multi-institutional review A Leone, B Gershman, K Rotker, C Butler, J Fantasia, A Miller, A Afiadata, A Amin, A Zhou, Z Jiang, T Sebo, A Mega, S Schiff, G Pareek, D Golijanin, J Yates, R J Karnes and J Renzulli Prostate Cancer Prostatic Dis 2016 19: 68-71; advance online publication, November 17, 2015; 10.1038/pcan.2015.52 Abstract | Full Text The influence of prednisone on the efficacy of docetaxel in men with metastatic castration-resistant prostate cancer B A Teply, B Luber, S R Denmeade and E S Antonarakis Prostate Cancer Prostatic Dis 2016 19: 72-78; advance online publication, November 17, 2015; 10.1038/pcan.2015.53 Abstract | Full Text A prospective clinical trial of HIFU hemiablation for clinically localized prostate cancer R van Velthoven, F Aoun, Q Marcelis, S Albisinni, M Zanaty, M Lemort, A Peltier and K Limani Prostate Cancer Prostatic Dis 2016 19: 79-83; advance online publication, November 24, 2015; 10.1038/pcan.2015.55 Abstract | Full Text Prostatectomy at high-volume centers improves outcomes and lowers the costs of care for prostate cancer A Barzi, E A Klein, T B Dorff, D I Quinn and S Sadeghi Prostate Cancer Prostatic Dis 2016 19: 84-91; advance online publication, December 15, 2015; 10.1038/pcan.2015.56 Abstract | Full Text Association of diet and lifestyle with chronic prostatitis/chronic pelvic pain syndrome and pain severity: a case–control study X Chen, C Hu, Y Peng, J Lu, N Q Yang, L Chen, G Q Zhang, L K Tang and J C Dai Prostate Cancer Prostatic Dis 2016 19: 92-99; advance online publication, December 15, 2015; 10.1038/pcan.2015.57 Abstract | Full Text A phase 2 multimodality trial of docetaxel/prednisone with sunitinib followed by salvage radiation therapy in men with PSA recurrent prostate cancer after radical prostatectomy A J Armstrong, S Halabi, P Healy, W R Lee, B F Koontz, J W Moul, K Mundy, P Creel, S Wood, K Davis, M A Carducci, M Stein, C Hobbs, B Reimer, M Nguyen, M Anand, L Bratt, S Kim, P T Tran, D J George and on behalf of Department of Defense Prostate Cancer Clinical Trials Consortium (DOD PCCTC) Prostate Cancer Prostatic Dis 2016 19: 100-106; advance online publication, January 12, 2016; 10.1038/pcan.2015.59 Abstract | Full Text Comparison of digit ratio (2D:4D) between Brazilian men with and without prostate cancer P H C Mendes, D R B Martelli, S de Melo Costa, E Gonçalves, C P Macedo, M F Silveira and H Martelli Júnior Prostate Cancer Prostatic Dis 2016 19: 107-110; advance online publication, January 12, 2016; 10.1038/pcan.2015.62 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Prostate Cancer and Prostatic Diseases. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.